Over the last few years, great emphasis has been given to develop ruthenium complexes to
act as target specified chemotherapeutic agents. Indeed, there are few reviews available …

This review focuses on studies of coordination and organometallic compounds as potential
chemotherapeutics against triple negative breast cancer (TNBC) which has one of the …

The synthesis and biological assessment of neutral or cationic platinum group metal-based
anticancer complexes have been extremely studied, whereas there are few reports on the …

The zebrafish (Danio rerio) is an emerging model system in several research areas
worldwide, especially in the Global South. In this context, the present study revised the …

Upon exploration of the chemistry of the combination of ruthenium/arene with anthraquinone
alizarin (L), three new complexes with the general formulas [Ru (L) Cl (η6-p …

We report the synthesis and photochemical and biological characterization of Ru (II)
complexes containing π-expansive ligands derived from dimethylbenzo [i] dipyrido [3, 2-a …

The preparation of two new Ru (II)/diphosphine complexes containing Lapachol (Lap) and
Lawsone (Law):(1)[Ru (Lap)(dppm) 2] PF 6 and (2)[Ru (Law)(dppm) 2] PF 6, where dppm …

Cancer is a perilous life-threatening disease, and attempts are constantly being made to
create multinuclear transition metal complexes that could lead to the development of …

We report here on three new ruthenium (II) complexes,[Ru (DPEPhos)(mtz)(bipy)] PF 6
(Ru1),[Ru (DPEPhos)(mmi)(bipy)] PF 6 (Ru2) and [Ru (DPEPhos)(dmp)(bipy)] PF 6 (Ru3) …

Synergistic drug combinations can extend the use of poly (ADP-ribose) polymerase
inhibitors (PARPi) such as Olaparib to BRCA-proficient tumors and overcome acquired or de …